Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 347

Similar articles for PubMed (Select 17956237)

1.

Peroxisomal disorders affecting phytanic acid alpha-oxidation: a review.

Wierzbicki AS.

Biochem Soc Trans. 2007 Nov;35(Pt 5):881-6. Review.

PMID:
17956237
2.

Refsum's disease: a peroxisomal disorder affecting phytanic acid alpha-oxidation.

Wierzbicki AS, Lloyd MD, Schofield CJ, Feher MD, Gibberd FB.

J Neurochem. 2002 Mar;80(5):727-35. Review.

PMID:
11948235
3.

Phytanic acid alpha-oxidation and complementation analysis of classical Refsum and peroxisomal disorders.

Poll-The BT, Skjeldal OH, Stokke O, Poulos A, Demaugre F, Saudubray JM.

Hum Genet. 1989 Jan;81(2):175-81.

PMID:
2463966
4.

Stereochemistry of the peroxisomal branched-chain fatty acid alpha- and beta-oxidation systems in patients suffering from different peroxisomal disorders.

Ferdinandusse S, Rusch H, van Lint AE, Dacremont G, Wanders RJ, Vreken P.

J Lipid Res. 2002 Mar;43(3):438-44.

5.

Phytanic acid: production from phytol, its breakdown and role in human disease.

van den Brink DM, Wanders RJ.

Cell Mol Life Sci. 2006 Aug;63(15):1752-65. Review.

PMID:
16799769
6.

Structure-function analysis of phytanoyl-CoA 2-hydroxylase mutations causing Refsum's disease.

Mukherji M, Chien W, Kershaw NJ, Clifton IJ, Schofield CJ, Wierzbicki AS, Lloyd MD.

Hum Mol Genet. 2001 Sep 1;10(18):1971-82.

8.

Peroxisomes, Refsum's disease and the alpha- and omega-oxidation of phytanic acid.

Wanders RJ, Komen JC.

Biochem Soc Trans. 2007 Nov;35(Pt 5):865-9. Review.

PMID:
17956234
9.

Studies on the oxidation of phytanic acid and pristanic acid in human fibroblasts by acylcarnitine analysis.

Verhoeven NM, Jakobs C, ten Brink HJ, Wanders RJ, Roe CR.

J Inherit Metab Dis. 1998 Oct;21(7):753-60.

PMID:
9819705
10.

Phytanic acid alpha-oxidation in peroxisomal disorders: studies in cultured human fibroblasts.

Verhoeven NM, Schor DS, Roe CR, Wanders RJ, Jakobs C.

Biochim Biophys Acta. 1997 Oct 24;1361(3):281-6.

PMID:
9375802
12.

Utilization of sterol carrier protein-2 by phytanoyl-CoA 2-hydroxylase in the peroxisomal alpha oxidation of phytanic acid.

Mukherji M, Kershaw NJ, Schofield CJ, Wierzbicki AS, Lloyd MD.

Chem Biol. 2002 May;9(5):597-605.

PMID:
12031666
13.

Phytanic acid must be activated to phytanoyl-CoA prior to its alpha-oxidation in rat liver peroxisomes.

Watkins PA, Howard AE, Mihalik SJ.

Biochim Biophys Acta. 1994 Oct 6;1214(3):288-94.

PMID:
7918611
14.

Structural and mechanistic studies on the peroxisomal oxygenase phytanoyl-CoA 2-hydroxylase (PhyH).

Schofield CJ, McDonough MA.

Biochem Soc Trans. 2007 Nov;35(Pt 5):870-5. Review.

PMID:
17956235
15.

Human metabolism of phytanic acid and pristanic acid.

Verhoeven NM, Jakobs C.

Prog Lipid Res. 2001 Nov;40(6):453-66. Review.

PMID:
11591435
16.
17.

Characterization of phytanic acid omega-hydroxylation in human liver microsomes.

Komen JC, Duran M, Wanders RJ.

Mol Genet Metab. 2005 Jul;85(3):190-5. Epub 2005 Mar 17.

PMID:
15979030
18.

The metabolism of phytanic acid and pristanic acid in man: a review.

Verhoeven NM, Wanders RJ, Poll-The BT, Saudubray JM, Jakobs C.

J Inherit Metab Dis. 1998 Oct;21(7):697-728. Review.

PMID:
9819701
19.

CYP4 isoform specificity in the omega-hydroxylation of phytanic acid, a potential route to elimination of the causative agent of Refsum's disease.

Xu F, Ng VY, Kroetz DL, de Montellano PR.

J Pharmacol Exp Ther. 2006 Aug;318(2):835-9. Epub 2006 May 17.

20.

Disorders related to the metabolism of phytanic acid.

Stokke O, Skjeldal OH, Høie K.

Scand J Clin Lab Invest Suppl. 1986;184:3-10. Review.

PMID:
2438746
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk